Neurocrine Biosciences
NBIX
#1681
Rank
ยฃ9.73 B
Marketcap
ยฃ96.98
Share price
-0.39%
Change (1 day)
6.06%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024: ยฃ0.45 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are ยฃ2.68 Billion. In 2024 the company made an earning of ยฃ0.45 Billion, an increase over its 2023 earnings that were of ยฃ0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024ยฃ0.45 B96.41%
2023ยฃ0.23 B41.13%
2022ยฃ0.16 B73.74%
2021ยฃ94.43 M-8.82%
2020ยฃ0.10 B77.78%
2019ยฃ58.25 M49.83%
2018ยฃ38.87 M-142.57%
2017-ยฃ91.33 Million-14.73%
2016-ยฃ0.11 Billion53.15%
2015-ยฃ69.94 Million46.25%
2014-ยฃ47.82 Million29.66%
2013-ยฃ36.88 Million-3530.8%
2012ยฃ1.07 M-95.73%
2011ยฃ25.18 M
2009-ยฃ35.41 Million-45.38%
2008-ยฃ64.81 Million-58.87%
2007-ยฃ0.16 Billion87.3%
2006-ยฃ84.13 Million351.97%
2005-ยฃ18.62 Million-52.09%
2004-ยฃ38.86 Million-10.98%
2003-ยฃ43.65 Million
2001-ยฃ32.58 Million
1999-ยฃ14.7 Million108.32%
1998-ยฃ7.06 Million
1996ยฃ2.15 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ8.79 B 1,932.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ1.23 B 184.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ16.70 B 3,758.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
ยฃ19.4 M-95.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ31.01 Million-107.16%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ37.52 M-91.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ3.56 Million-100.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
ยฃ1.17 B 171.24%๐Ÿ‡ฌ๐Ÿ‡ง UK